Posted on 08/03/2021 12:32:14 PM PDT by Blue Turtle
damn good question!
thank you.
thank you
The problem is these passive antibodies only last about 4’weeks then are degraded. For lasting protection. you need to stimulate your immune system to make it’s own. antibodies either through vaccination or infection
Waiting to see if an aborted baby was used in any way like the other 3
Can I get some at Tractor Supply Co.?
and yet....people who were sick months ago had problems getting it
probably because it is a Trump drug
https://www.theatlantic.com/science/archive/2020/10/trumps-regeneron-antibodies-covid/616683/
The shot version of this might be easier to get with your insurance company.
Mine requires pre approval for infusions. I have wondered how fast that would happen if I get a Covid positive test on a Friday and have to wait for approval.
There is a small window to use the infusions.
caveat: early treatment and for certain hospitalized . Most likely to benefit are those who have already advanced to needing supplemental o2.
US cost per dose is about $500 plus cost of daily infusion, (india recommends 10 day course so that would be $5K with a rx discount card) so don’t count on it to become widely avail on demand.
Remdesivir Priced At More Than $3,100 For A Course Of Treatment “How much uninsured patients would pay is still unclear.”
https://www.npr.org/sections/health-shots/2020/06/29/884648842/remdesivir-priced-at-more-than-3-100-for-a-course-of-treatment
Medicare caveat: inpatient only
“For Medicare patients, this will be one of the limited instances when prescription drugs are covered by Medicare Part A. Remdesivir will be covered under Part A when administered as part of inpatient hospital care,”
https://www.medicareadvantage.com/news/remdesivir-cost
(from the NIH study:) “ Remdesivir appeared to most benefit patients who were receiving supplemental oxygen...). All-cause mortality among all patients was 11% with remdesivir and 15% with placebo at day 29, but this difference between the treatment groups was not large enough to rule out chance. The preliminary findings hadn’t shown an effect on mortality....
The findings show that remdesivir alone isn’t a sufficient treatment for all patients but does provide some benefit. “
” in sicker populations, it didn’t really change outcomes,” said Dr. Ken Lyn-Kew, a pulmonologist in the critical care section at National Jewish Health in Denver.”
The WHO “Solidarity Study” says:
“analyzing data from four randomized international trials with 7,000 patients hospitalized for COVID-19. The trials showed the drug had “no meaningful effect on mortality or on other important outcomes for patients, such as the need for mechanical ventilation or time to clinical improvement,” according to the WHO. The panel also said the high-cost and difficulty of administering the drug (intravenously) were also factors in its recommendation.”
Ping for later.
from India, April 20, 2021:
’ Indian authorities claim that Remdesivir is not a life-saving drug and it’s unnecessary use is unethical.
” Dr. Randeep Guleria, the director of the All India Institute of Medical Sciences (AIIMS) Delhi said on Monday, “Remdesivir isn’t magic bullet and isn’t a drug that decreases mortality.”
“We may use Remdesivir as we don’t have an anti-viral drug. Remdesivir was proven useful for those in hospitals and on oxygen...it can’t be taken like a regular antibiotic,” he added.
He further emphasized that the anti-viral drug must only be given to people who are hospitalised, have a fall in oxygen saturation and have infiltrates on the chest X-ray or CT-scan.”
Qui bono
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.